Published in Pol Arch Med Wewn on November 01, 1970
Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas. Br J Surg (2010) 1.73
Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med (2013) 1.57
Intracapillary leucocyte accumulation as a novel antihaemorrhagic mechanism in acute pancreatitis in mice. Gut (2009) 1.56
[Prostrating form of hyperthyroidism]. Pol Tyg Lek (1972) 1.42
Transfusion-related acute lung injury due to granulocyte-agglutinating antibody in a patient with paroxysmal nocturnal hemoglobinuria. Transfusion (1999) 1.39
Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study. Leukemia (2004) 1.13
Effect of matrix metalloproteinase inhibition on pancreatic cancer invasion and metastasis: an additive strategy for cancer control. Ann Surg (2000) 1.10
Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy. Ann Surg (1999) 1.08
Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine. Eur J Cancer (2004) 1.04
Surgery in the treatment of acute pancreatitis--open pancreatic necrosectomy. Scand J Surg (2005) 1.03
Immunohistochemical characterization of pancreatic tumors induced by dimethylbenzanthracene in rats. Am J Pathol (1999) 1.02
Outbreak of vancomycin-resistant Enterococcus faecium of the phenotype VanB in a hospital in Warsaw, Poland: probable transmission of the resistance determinants into an endemic vancomycin-susceptible strain. J Clin Microbiol (2001) 0.97
Recurrence of thrombocytopenia in patients splenectomized for idiopathic thrombocytopenic purpura. Blut (1981) 0.92
[Treatment of acromegaly by the surgical approach through the sphenoid bone. I. Clinical results]. Neurol Neurochir Pol (1983) 0.89
The results of prolonged treatment of autoimmune haemolytic anaemia. Haematologia (Budap) (1981) 0.87
[Antibodies directed against adrenal glands in Addison's and Cushing's diseases]. Pol Arch Med Wewn (1971) 0.86
2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland. Eur J Haematol (1999) 0.86
Persistence of some polychlorinated dibenzo-p-dioxins and polychlorinated dibenzofurans of pentachlorophenol in human adipose tissue. Rocz Panstw Zakl Hig (1984) 0.84
Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG). Ann Hematol (2006) 0.84
The use of vinca alkaloids in adult patients with refractory chronic idiopathic thrombocytopenia. Clin Lab Haematol (2004) 0.83
Vitamin B 12 metabolism in adrenocortical insufficiency. Haematologia (Budap) (1970) 0.83
[Central patient management in surgery]. Chirurg (2002) 0.83
Platelet function in acute experimental pancreatitis induced by ischaemia-reperfusion. Br J Surg (2005) 0.82
[Asthma states in the course of hyperthyreosis]. Gruzlica (1968) 0.82
Assessment of nutritional folate status and selected vitamin status of women of childbearing age. Eur J Clin Nutr (2001) 0.82
[Reduction of local and systemic complications of acute pancreatitis by monoclonal antibody to ICAM-1]. Langenbecks Arch Chir Suppl Kongressbd (1998) 0.81
An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma. Br J Cancer (2004) 0.81
[Leukostasis syndrome in a case of chronic lymphocytic leukemia]. Pol Merkur Lekarski (1999) 0.80
Endogenous natriuretic factors: atrial natriuretic hormone and digitalis-like substance in Cushing's syndrome. J Endocrinol (1991) 0.80
Haem synthesis in sideroblastic anaemia. Br J Haematol (1979) 0.79
Nelson's syndrome: incidence and prognosis. Clin Endocrinol (Oxf) (1983) 0.79
Cladribine with or without prednisone in the treatment of previously treated and untreated B-cell chronic lymphocytic leukaemia - updated results of the multicentre study of 378 patients. Br J Haematol (2000) 0.79
[Results of surgical treatment of 111 cases of adrenocortical hyperfunction (an analysis)]. Endokrynol Pol (1978) 0.78
Quality of life after emergency vs. elective esophagectomy with cervical reconstruction. Scand J Surg (2010) 0.78
Disturbances of cell-mediated immunity in ornithosis. Arch Immunol Ther Exp (Warsz) (1984) 0.78
2-chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemia. Leuk Lymphoma (1996) 0.78
The effect of 2-h infusion of 2-chlorodeoxyadenosine (cladribine) with prednisone in previously untreated B-cell chronic lymphocytic leukaemia. Eur J Cancer (1997) 0.77
The use of vinca alkaloids in preparation for splenectomy of corticosteroid refractory chronic immune thrombocytopenic purpura patients. Int J Lab Hematol (2007) 0.77
Autoimmune haemolytic anaemia in patients with chronic lymphocytic leukaemia treated with 2-chlorodeoxyadenosine (cladribine). Eur J Haematol (1997) 0.76
Long-term outcome of splenectomy for immune thrombocytopenic purpura. Am J Hematol (2004) 0.75
[Therapeutic and clinical problems in the meningeal and cerebral forms of acute leukemia]. Acta Haematol Pol (1979) 0.75
[Autoimmunologic aspects of Addison-Biermer disease]. Pol Tyg Lek (1971) 0.75
[Effect of vitamin B-4 on leukopoiesis]. Pol Tyg Lek (1972) 0.75
[Cytogenetic studies of spleen cells in some myeloproliferative syndromes]. Acta Haematol Pol (1973) 0.75
[Kinetics of radioactive iron F-59 and erythrokinetics of Cr-51 in anemia in patients with burns]. Pol Tyg Lek (1966) 0.75
[Studies on the kinetics of Fe-59 and erythrokinetics of Cr-51 in chronic lymphatic leukemias]. Nowotwory (1967) 0.75
[Australia antigen: new discoveries and hypotheses]. Acta Haematol Pol (1973) 0.75
Results of splenectomy in hemolytic syndromes on the basis of clinical, hematologic and isotope indications. Pol Med J (1968) 0.75
[Chromosomal abnormalities in Di Guglielmo's syndrome]. Nowotwory (1966) 0.75
[Role of splenectomy in present-day hematology]. Pol Arch Med Wewn (1978) 0.75
[Kinetics of radioactive iron in blood donors]. Acta Haematol Pol (1973) 0.75
[Results of treatment of autoimmune hemolytic anemias]. Pol Tyg Lek (1978) 0.75
[Advances in the treatment of acute leukemia in adults]. Acta Haematol Pol (1974) 0.75
[Principles of therapy with blood and its derivatives]. Pol Tyg Lek (1965) 0.75
[Autoimmune connections between diabetes and Addison-Biermeier disease]. Pol Tyg Lek (1973) 0.75
Intensive chemotherapy of acute leukaemias in adults. Preliminary communication. Mater Med Pol (1978) 0.75
[Determination of vitamin B 12 in blood serum by isotope methods]. Pol Arch Med Wewn (1968) 0.75
[Pseudoleukemoid reactions]. Pol Tyg Lek (1971) 0.75
[Comparative testing of the iron binding capacity of the blood serum by biological and isotope methods]. Pol Tyg Lek (1965) 0.75
Treatment of 100 cases of chronic myeloid leukemia with Myleran. Pol Med Sci Hist Bull (1968) 0.75
[Immunological status and the results of levamisole treatment of patients with lymphocytic leukemia]. Pol Tyg Lek (1980) 0.75
[Chemotherapy in generalized malignant lymphoma]. Pol Tyg Lek (1978) 0.75
[Pyruvate kinase activity of erythrocytes in hereditary non-spherocytic hemolytic anemias]. Pol Arch Med Wewn (1968) 0.75
[In memoriam: Prof. Robert Waitz]. Acta Haematol Pol (1979) 0.75
[Studies on the pathogenesis of anemia in Hodgkin's disease]. Pol Tyg Lek (1966) 0.75
[Results of treatment of lymphogranulomatosis with Natulan]. Nowotwory (1969) 0.75
Radioactive iron kinetics in blood donors. Blut (1972) 0.75
Evaluation of criteria for splenectomy in hemolytic anemias. Pol Med Sci Hist Bull (1968) 0.75
[Observations on the thrombolytic treatment of coronary thrombosis]. Pol Tyg Lek (1966) 0.75
[Role of autoimmune mechanisms in Addison-Biermer disease]. Acta Haematol Pol (1973) 0.75
[Results of intensive cytostatic treatment of blastic exacerbation of chronic myeloid leukemia]. Pol Tyg Lek (1978) 0.75
[Intracellular cAMP concentration in isolated cells of white blood cell series of peripheral blood and bone marrow in healthy subjects and patients with different proliferative syndromes]. Acta Haematol Pol (1978) 0.75
[The hypothalamo-pituitary-adrenocortical system in chronic leukemias]. Acta Haematol Pol (1974) 0.75
[Treatment of chronic lymphatic leukemia with heterologous antilymphocytic serum. I. Obtaining of heterologous serum against lymphocytes of chronic lymphatic leukemia]. Acta Haematol Pol (1973) 0.75
Occurrence of malignant neoplasms in patients with chronic lymphatic leukaemia. Haematologia (Budap) (1977) 0.75
Autoimmunological mechanisms in Addison-Biermer's disease. Folia Haematol Int Mag Klin Morphol Blutforsch (1971) 0.75
Pyruvate kinase activity of erythrocytes in hereditary non-spherocytic hemolytic anemias. Pol Med J (1969) 0.75
[In memoriam: Professor E. Perlick]. Acta Haematol Pol (1973) 0.75
[Autoimmune hemolytic anemias]. Acta Haematol Pol (1973) 0.75
[Delayed results of splenectomy in chronic idiopathic thrombocytopenia in children]. Pediatr Pol (1978) 0.75
Radiological, haematological and histological analysis of myelosclerosis. Folia Haematol Int Mag Klin Morphol Blutforsch (1973) 0.75
[Results of cytosine arabinoside treatment in adult patients with acute myeloblastic leukemia]. Acta Haematol Pol (1974) 0.75
Comparison of the results of combined treatment of acute myeloblastic leukemias with corticosteroids and either imuran or 6-mercaptopurine. Pol Med J (1971) 0.75
[Diagnostic problems in certain dysimmunoglobulinemias]. Pol Tyg Lek (1968) 0.75
[Kinetics of iron radioisotopes and survival of chromium radioisotope conjugated erythrocytes in patients following post-traumatic spenectomy]. Acta Haematol Pol (1974) 0.75
[Radiological, hematologic and histologic analysis of myelo-osteosclerosis]. Acta Haematol Pol (1973) 0.75
[Methemoglobulinemia due to failure of the erythrocyte reducing systems]. Pol Arch Med Wewn (1968) 0.75
[Interactions between pregnancy and leukemia]. Acta Haematol Pol (1974) 0.75
[Recurrence of hemorrhagic diathesis in patients splenectomized for idiopathic thrombocytopenic purpura]. Pol Tyg Lek (1978) 0.75
[Analysis of positive results of treatment of autoimmune hemolytic anemia]. Pol Tyg Lek (1979) 0.75
[Treatment of leukemic infiltrations of the central nervous system. Preliminary communication]. Acta Haematol Pol (1979) 0.75
A comparison of the iron-binding capacity of the serum studied by means of biochemical and isotope methods. Pol Med J (1966) 0.75
[Analysis of results of treatment with myleran in 100 cases of chronic myelogenous leukemia]. Pol Arch Med Wewn (1968) 0.75